“As Bayer, we hope that the ACLP will attract as many European breeders as possible to ensure the broadest possible commercialization of novel patented traits resulting from innovation in modern breeding technologies and trait research. Balancing access to, and legal protection of,  innovative traits in a transparent way is vital to meet the challenges facing European agriculture.“